1. Home
  2. RZLT vs NAUT Comparison

RZLT vs NAUT Comparison

Compare RZLT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.55

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$2.39

Market Cap

305.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RZLT
NAUT
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
326.4M
305.7M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RZLT
NAUT
Price
$2.55
$2.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$9.17
$4.00
AVG Volume (30 Days)
2.1M
220.0K
Earning Date
05-27-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
26.32
16.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$992.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.62
52 Week High
$11.46
$3.08

Technical Indicators

Market Signals
Indicator
RZLT
NAUT
Relative Strength Index (RSI) 33.21 49.43
Support Level $1.87 $1.82
Resistance Level $2.82 $3.08
Average True Range (ATR) 0.25 0.27
MACD -0.07 -0.04
Stochastic Oscillator 10.16 23.08

Price Performance

Historical Comparison
RZLT
NAUT

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: